Medical Properties Trust, Inc. (MPT) Stock Forecast
Data as of Aug 1, 2026Real Estate · Current price $4.62 (-1.07%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 11, 2025 | Nate Crossett | BNP Paribas | $9.00 | +94.8% |
| Sep 13, 2024 | Michael Lewis | Truist Financial | $6.00 | +29.9% |
| Sep 13, 2024 | David Toti | Colliers Securities | $6.50 | +40.7% |
| Sep 12, 2024 | Vikram Malhotra | Mizuho Securities | $7.00 | +51.5% |
| Aug 2, 2024 | Dori Kesten | Wells Fargo | $7.50 | +62.3% |
| Aug 2, 2024 | Michael Lewis | Truist Financial | $8.00 | +73.2% |
| Jul 1, 2024 | Nate Crossett | BNP Paribas | $4.00 | -13.4% |
| May 29, 2024 | Michael Lewis | Truist Financial | $5.00 | +8.2% |
| May 13, 2024 | Michael Carroll | RBC Capital | $5.00 | +8.2% |
| Apr 17, 2024 | Omotayo Okusanya | Deutsche Bank | $5.00 | +8.2% |
| Apr 8, 2024 | Michael Lewis | Truist Financial | $4.50 | -2.6% |
| Aug 14, 2023 | Michael Carroll | RBC Capital | $10.00 | +116.5% |
| Apr 22, 2022 | Jonathan Petersen | Jefferies | $20.00 | +332.9% |
| Nov 23, 2021 | Steven Valiquette | Barclays | $27.00 | +484.4% |
| Oct 29, 2021 | Jonathan Hughes | Raymond James | $26.00 | +462.8% |
| May 4, 2021 | Jordan Sadler | KeyBanc | $24.00 | +419.5% |
Top Analysts Covering MPT
MPT vs Sector & Market
| Metric | MPT | Real Estate Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.60 | 2.42 |
| Analyst Count | 2 | 9 | 19 |
| Target Upside | +73.2% | +45.2% | +17.1% |
| P/E Ratio | -11.21 | 27.94 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $248M | $250M | $251M | 1 |
| 2026-12-31 | $258M | $259M | $261M | 1 |
| 2027-03-31 | $263M | $264M | $266M | 1 |
| 2027-06-30 | $263M | $265M | $266M | 1 |
| 2027-09-30 | $263M | $265M | $266M | 1 |
| 2027-12-31 | $263M | $265M | $266M | 1 |
| 2028-12-31 | $1.05B | $1.07B | $1.11B | 1 |
| 2029-12-31 | $1.09B | $1.11B | $1.14B | 1 |
| 2030-12-31 | $1.12B | $1.14B | $1.18B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.03 | $0.03 | $0.03 | 1 |
| 2026-12-31 | $0.03 | $0.03 | $0.03 | 1 |
| 2027-03-31 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-06-30 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-09-30 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-12-31 | $0.03 | $0.03 | $0.03 | 1 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for MPT?
The consensus among 2 analysts covering Medical Properties Trust, Inc. (MPT) is Hold with an average price target of $8.00.
What is the highest price target for MPT?
The highest price target for MPT is $27.00, set by Steven Valiquette at Barclays on 2021-11-23.
What is the lowest price target for MPT?
The lowest price target for MPT is $4.00, set by Nate Crossett at BNP Paribas on 2024-07-01.
How many analysts cover MPT?
2 analysts have issued ratings for Medical Properties Trust, Inc. in the past 12 months.
Is MPT a buy or sell right now?
Based on 2 analyst ratings, MPT has a consensus rating of Hold (3.00/5) with a +73.2% upside to the consensus target of $8.00.
What are the earnings estimates for MPT?
Analysts estimate MPT will report EPS of $0.03 for the period ending 2026-09-30, with revenue estimated at $250M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.